Hypervitaminosis A with fulminant secondary intracranial hypertension following personalized medicine-based Elexacaftor/Tezacaftor/Ivacaftor initiation in a preadolescent with cystic fibrosis
Authors:
- 4 February 2022
- journal article
- research article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 21 (3) , e217-e220
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Elexacaftor/Tezacaftor/Ivacaftor Improved Clinical Outcomes in a Patient with N1303K-CFTR Based on In Vitro Experimental EvidenceAmerican Journal of Respiratory and Critical Care Medicine, 2021
- Case Series of Rapid Surgical Interventions in Fulminant Intracranial HypertensionJournal of Child Neurology, 2021
- Pediatric Intracranial HypertensionPediatric Neurology, 2017
- Vitamin A intake and serum retinol levels in children and adolescents with cystic fibrosisClinical Nutrition, 2016
- Vitamin A levels in patients with CF are influenced by the inflammatory responseJournal of Cystic Fibrosis, 2004
- Increased Intracranial Pressure Following Treatment of Cystic FibrosisPediatrics, 1980
- VITAMIN A INTOXICATION AS A CAUSE OF PSEUDOTUMOR CEREBRIJAMA, 1960